Why is Bliss GVS Pharma falling/rising?

As of 30-Jul, Bliss GVS Pharma Ltd's stock is rising, with a current price of Rs 184.05, reflecting an increase of Rs 27.35 or 17.45%. The stock has recently hit a new 52-week high of Rs 186.75 and has shown strong performance, gaining 20.18% over the last four days. It has outperformed its sector by 17.11% today and is trading above all key moving averages. Despite a decline in delivery volume by 13.06% against the five-day average, the stock has demonstrated impressive returns of 51.11% over the past year and has consistently outperformed the BSE500 index over various periods, indicating robust market performance. However, it is important to note that the company's profits have decreased by 3.6% during this time.
In the broader market context, Bliss GVS Pharma's short-term return of 17.34% over the past week stands in stark contrast to the Sensex, which has declined by 1.50%. This significant outperformance highlights the stock's strength relative to the overall market. While the company maintains a low debt-to-equity ratio and a fair valuation, it is trading at a premium compared to its peers. The stock's ability to generate substantial returns while facing a slight decline in profits suggests that investor sentiment remains positive, contributing to its rising price amidst a challenging market environment.